Policy & Regulation
AMO Pharma Limited names new CFO & board member
14 October 2021 -

Biopharmaceutical company AMO Pharma Limited reported on Thursday the addition of Julia Jones as chief financial officer (CFO) as well as a member of its board of directors.

As part of the pharma team, Jones said she will apply her experience to help the company maximize the full range of opportunities associated with their leadership in research and product development based on continuing progress in their late-stage clinical programmes.

Previously, Jones was a chartered accountant at PricewaterhouseCoopers as well as founder of Archangel Accounting Ltd, a UK-based finance and accounting firm, where she provided senior counsel and services to many public and private life sciences companies.

According to the company, Jones has an established record of supporting life sciences companies at every stage of development from start up through to exit and has helped companies secure and manage significant investments in venture capital funding.